Advanced Heart Failure

Key dilated cardiomyopathy publications, presentations and abstracts of Vericel Corporation are listed in chronological order below and available for download in PDF.

Journal Articles

Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial
Amit N Patel*, Timothy D Henry*, Arshed A Quyyumi, Gary L Schaer, R David Anderson, Catalin Toma, Cara East, Ann E Remmers, James Goodrich, Akshay S Desai, David Recker, Anthony DeMaria, for The ixCELL-DCM Investigators The Lancet. Volume 387, No. 10036, p2412-2421, 11 June 2016.

The iXCELL-DCM Trial: Rationale and Design
Timothy D. Henry, Gary L. Schaer, Anthony DeMaria, David Recker, Ann E. Remmers, James Goodrich, Amit Patel. CT-1575 Cell Transplantation early e-pub; March 21, 2016.

Safety and Efficacy of Ixmyelocel-T: An Expanded, Autologous Multi-Cellular Therapy, in Dilated Cardiomyopathy
Timothy D. Henry, Jay H Traverse, Baron L. Hammon, Cara A. East, Brian Bruckner, Ann E. Remmers, David Recker, David A. Bull, and Amit N. Patel. Circulation Research, August 20, 2014.

Safety and Efficacy of Ixmyelocel-T, An Expanded, Autologous Multi-Cellular Therapy, Therapeutic potential of ixmyelocel-T, an expanded autologous multicellular therapy for treatment of ischemic cardiovascular diseases
Kelly J Ledford, Nikki Murphy, Frank Zeigler, Ronnda L Bartel and Ross Tubo. Stem Cell Research & Therapy (2015) 6:25

Potential Beneficial Effects of Ixmyelocel-T in the Treatment of Atherosclerotic Diseases
KJ Ledford, N Murphy, F Zeigler, RL Bartel. Stem Cell Research & Therapy, November 2013.

Ixmyelocel-T, an expanded multicellular therapy, contains a unique population of M2-like macrophages
KJ Ledford, F Zeigler, RL Bartel. Stem Cell Research & Therapy, November 2013.

Safety and Efficacy of Ixmyelocel-T, An Expanded Patient-Specific Mixed Cell Product, in Dilated Cardiopyopathy (IMPACT-DCM)
Brian Bruckner, Amit N. Patel, Baron L. Hamman, Omar M. Lattouf, Nicholas G. Smedira, Ronnda L. Bartel, and Sharon Watling. International Society for Heart and Lung Transplantation, November 2011.

Tissue Repair Cells for the Treatment of Cardiovascular Diseases
K. Goltry, J. Rowley, M. Peters, E. Burchardt. Advances in Molecular Medicine, Vol. 3(1): 5-13, 2007.

Presentations & Posters